Bio Path | BPTH - Ordinary Share Capital


Bio Path reported $9.24M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Alterity Therapeutics Limited AUD 10.88B 10.66B Dec/2025
Baxter International USD 514.28M 168.72M Dec/2025
Bio Path USD 9.24M 934K Sep/2025
Cipla INR 807.77M 807.43M Sep/2025
Clal Biotechnology ILS 1.61M 0 Dec/2022
Compugen USD 94.55M 1.02M Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Grifols EUR 680.58M 846.11K Dec/2025
Karyopharm Therapeutics USD 18.31M 18.3M Dec/2025